Clinical Trial Update: SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating SRK-181 alone or in combination with anti-PD-(L)1 therapy in locally advanced or metastatic solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• SRK-181

Snippet

Sponsor: Scholar Rock, Inc. | Conditions: Cancer | Phase 1 | Status: COMPLETED